Deficiency of fibroblast growth factor-inducible 14 (Fn14) preserves the filtration barrier and ameliorates lupus nephritis

Yumin Xia, Leal C. Herlitz, Simona Gindea, Jing Wen, Rahul D. Pawar, Alexander Misharin, Harris Perlman, Lan Wu, Ping Wu, Jennifer S. Michaelson, Linda C. Burkly, Chaim Putterman

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

TNF ligand superfamily member 12, also known as TNF-related weak inducer of apoptosis (TWEAK), acts through its receptor, fibroblast growth factor-inducible 14 (Fn14), to mediate several key pathologic processes involved in tissue injury relating to lupus nephritis. To explore the potential for renal protection in lupus nephritis by targeting this pathway, we introduced the Fn14 null allele into the MRL-lpr/lpr lupus mouse strain. At 26-38 weeks of age, female Fn14-knockout MRL-lpr/lpr mice had significantly lower levels of proteinuria compared with female wild-type MRL-lpr/lpr mice. Furthermore, Fn14-knockout mice had significantly improved renal histopathology accompanied by attenuated glomerular and tubulointerstitial inflammation. There was a significant reduction in glomerular Ig deposition in Fn14-knockout mice, despite no detectable differences in either serum levels of antibodies or splenic immune cell subsets. Notably, we found that the Fn14-knockout mice displayed substantial preservation of podocytes in glomeruli and that TWEAK signaling directly damaged barrier function and increased filtration through podocyte and glomerular endothelial cell monolayers. Our results show that deficiency of the Fn14 receptor significantly improves renal disease in a spontaneous lupus nephritis model through prevention of the direct injurious effects of TWEAK on the filtration barrier and/or modulation of cytokine production by resident kidney cells. Thus, blocking the TWEAK/Fn14 axis may be a novel therapeutic intervention in immune-mediated proliferative GN.

Original languageEnglish (US)
Pages (from-to)1053-1070
Number of pages18
JournalJournal of the American Society of Nephrology
Volume26
Issue number5
DOIs
StatePublished - May 1 2015

Fingerprint

Lupus Nephritis
Knockout Mice
Kidney
Podocytes
Age Factors
Pathologic Processes
Proteinuria
Endothelial Cells
Alleles
Apoptosis
Cytokines
Ligands
Inflammation
fibroblast growth factor 14
Antibodies
Wounds and Injuries
Serum
Therapeutics

ASJC Scopus subject areas

  • Nephrology

Cite this

Deficiency of fibroblast growth factor-inducible 14 (Fn14) preserves the filtration barrier and ameliorates lupus nephritis. / Xia, Yumin; Herlitz, Leal C.; Gindea, Simona; Wen, Jing; Pawar, Rahul D.; Misharin, Alexander; Perlman, Harris; Wu, Lan; Wu, Ping; Michaelson, Jennifer S.; Burkly, Linda C.; Putterman, Chaim.

In: Journal of the American Society of Nephrology, Vol. 26, No. 5, 01.05.2015, p. 1053-1070.

Research output: Contribution to journalArticle

Xia, Y, Herlitz, LC, Gindea, S, Wen, J, Pawar, RD, Misharin, A, Perlman, H, Wu, L, Wu, P, Michaelson, JS, Burkly, LC & Putterman, C 2015, 'Deficiency of fibroblast growth factor-inducible 14 (Fn14) preserves the filtration barrier and ameliorates lupus nephritis', Journal of the American Society of Nephrology, vol. 26, no. 5, pp. 1053-1070. https://doi.org/10.1681/ASN.2014030233
Xia, Yumin ; Herlitz, Leal C. ; Gindea, Simona ; Wen, Jing ; Pawar, Rahul D. ; Misharin, Alexander ; Perlman, Harris ; Wu, Lan ; Wu, Ping ; Michaelson, Jennifer S. ; Burkly, Linda C. ; Putterman, Chaim. / Deficiency of fibroblast growth factor-inducible 14 (Fn14) preserves the filtration barrier and ameliorates lupus nephritis. In: Journal of the American Society of Nephrology. 2015 ; Vol. 26, No. 5. pp. 1053-1070.
@article{8e69707959a04134911d0339e9b481ba,
title = "Deficiency of fibroblast growth factor-inducible 14 (Fn14) preserves the filtration barrier and ameliorates lupus nephritis",
abstract = "TNF ligand superfamily member 12, also known as TNF-related weak inducer of apoptosis (TWEAK), acts through its receptor, fibroblast growth factor-inducible 14 (Fn14), to mediate several key pathologic processes involved in tissue injury relating to lupus nephritis. To explore the potential for renal protection in lupus nephritis by targeting this pathway, we introduced the Fn14 null allele into the MRL-lpr/lpr lupus mouse strain. At 26-38 weeks of age, female Fn14-knockout MRL-lpr/lpr mice had significantly lower levels of proteinuria compared with female wild-type MRL-lpr/lpr mice. Furthermore, Fn14-knockout mice had significantly improved renal histopathology accompanied by attenuated glomerular and tubulointerstitial inflammation. There was a significant reduction in glomerular Ig deposition in Fn14-knockout mice, despite no detectable differences in either serum levels of antibodies or splenic immune cell subsets. Notably, we found that the Fn14-knockout mice displayed substantial preservation of podocytes in glomeruli and that TWEAK signaling directly damaged barrier function and increased filtration through podocyte and glomerular endothelial cell monolayers. Our results show that deficiency of the Fn14 receptor significantly improves renal disease in a spontaneous lupus nephritis model through prevention of the direct injurious effects of TWEAK on the filtration barrier and/or modulation of cytokine production by resident kidney cells. Thus, blocking the TWEAK/Fn14 axis may be a novel therapeutic intervention in immune-mediated proliferative GN.",
author = "Yumin Xia and Herlitz, {Leal C.} and Simona Gindea and Jing Wen and Pawar, {Rahul D.} and Alexander Misharin and Harris Perlman and Lan Wu and Ping Wu and Michaelson, {Jennifer S.} and Burkly, {Linda C.} and Chaim Putterman",
year = "2015",
month = "5",
day = "1",
doi = "10.1681/ASN.2014030233",
language = "English (US)",
volume = "26",
pages = "1053--1070",
journal = "Journal of the American Society of Nephrology : JASN",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "5",

}

TY - JOUR

T1 - Deficiency of fibroblast growth factor-inducible 14 (Fn14) preserves the filtration barrier and ameliorates lupus nephritis

AU - Xia, Yumin

AU - Herlitz, Leal C.

AU - Gindea, Simona

AU - Wen, Jing

AU - Pawar, Rahul D.

AU - Misharin, Alexander

AU - Perlman, Harris

AU - Wu, Lan

AU - Wu, Ping

AU - Michaelson, Jennifer S.

AU - Burkly, Linda C.

AU - Putterman, Chaim

PY - 2015/5/1

Y1 - 2015/5/1

N2 - TNF ligand superfamily member 12, also known as TNF-related weak inducer of apoptosis (TWEAK), acts through its receptor, fibroblast growth factor-inducible 14 (Fn14), to mediate several key pathologic processes involved in tissue injury relating to lupus nephritis. To explore the potential for renal protection in lupus nephritis by targeting this pathway, we introduced the Fn14 null allele into the MRL-lpr/lpr lupus mouse strain. At 26-38 weeks of age, female Fn14-knockout MRL-lpr/lpr mice had significantly lower levels of proteinuria compared with female wild-type MRL-lpr/lpr mice. Furthermore, Fn14-knockout mice had significantly improved renal histopathology accompanied by attenuated glomerular and tubulointerstitial inflammation. There was a significant reduction in glomerular Ig deposition in Fn14-knockout mice, despite no detectable differences in either serum levels of antibodies or splenic immune cell subsets. Notably, we found that the Fn14-knockout mice displayed substantial preservation of podocytes in glomeruli and that TWEAK signaling directly damaged barrier function and increased filtration through podocyte and glomerular endothelial cell monolayers. Our results show that deficiency of the Fn14 receptor significantly improves renal disease in a spontaneous lupus nephritis model through prevention of the direct injurious effects of TWEAK on the filtration barrier and/or modulation of cytokine production by resident kidney cells. Thus, blocking the TWEAK/Fn14 axis may be a novel therapeutic intervention in immune-mediated proliferative GN.

AB - TNF ligand superfamily member 12, also known as TNF-related weak inducer of apoptosis (TWEAK), acts through its receptor, fibroblast growth factor-inducible 14 (Fn14), to mediate several key pathologic processes involved in tissue injury relating to lupus nephritis. To explore the potential for renal protection in lupus nephritis by targeting this pathway, we introduced the Fn14 null allele into the MRL-lpr/lpr lupus mouse strain. At 26-38 weeks of age, female Fn14-knockout MRL-lpr/lpr mice had significantly lower levels of proteinuria compared with female wild-type MRL-lpr/lpr mice. Furthermore, Fn14-knockout mice had significantly improved renal histopathology accompanied by attenuated glomerular and tubulointerstitial inflammation. There was a significant reduction in glomerular Ig deposition in Fn14-knockout mice, despite no detectable differences in either serum levels of antibodies or splenic immune cell subsets. Notably, we found that the Fn14-knockout mice displayed substantial preservation of podocytes in glomeruli and that TWEAK signaling directly damaged barrier function and increased filtration through podocyte and glomerular endothelial cell monolayers. Our results show that deficiency of the Fn14 receptor significantly improves renal disease in a spontaneous lupus nephritis model through prevention of the direct injurious effects of TWEAK on the filtration barrier and/or modulation of cytokine production by resident kidney cells. Thus, blocking the TWEAK/Fn14 axis may be a novel therapeutic intervention in immune-mediated proliferative GN.

UR - http://www.scopus.com/inward/record.url?scp=84929307614&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929307614&partnerID=8YFLogxK

U2 - 10.1681/ASN.2014030233

DO - 10.1681/ASN.2014030233

M3 - Article

VL - 26

SP - 1053

EP - 1070

JO - Journal of the American Society of Nephrology : JASN

JF - Journal of the American Society of Nephrology : JASN

SN - 1046-6673

IS - 5

ER -